Proline metabolism and microenvironmental stress.

James M Phang, Wei Liu, Olga Zabirnyk
Author Information
  1. James M Phang: Metabolism and Cancer Susceptibility Section, Laboratory of Comparative Carcinogenesis, Center for Cancer Research, NCI at Frederick, Frederick, Maryland 21702, USA. phangj@mail.nih.gov

Abstract

Proline, the only proteinogenic secondary amino acid, is metabolized by its own family of enzymes responding to metabolic stress and participating in metabolic signaling. Collagen in extracellular matrix, connective tissue, and bone is an abundant reservoir for proline. Matrix metalloproteinases degrading collagen are activated during stress to make proline available, and proline oxidase, the first enzyme in proline degradation, is induced by p53, peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands, and by AMP-activated protein kinase downregulating mTOR. Metabolism of proline generates electrons to produce ROS and initiates a variety of downstream effects, including blockade of the cell cycle, autophagy, and apoptosis. The electrons can also enter the electron transport chain to produce adenosine triphosphate for survival under nutrient stress. Pyrroline-5-carboxylate, the product of proline oxidation, is recycled back to proline with redox transfers or is sequentially converted to glutamate and alpha-ketoglutarate. The latter augments the prolyl hydroxylation of hypoxia-inducible factor-1alpha and its proteasomal degradation. These effects of proline oxidase, as well as its decreased levels in tumors, support its role as a tumor suppressor. The mechanism for its decrease is mediated by a specific microRNA. The metabolic signaling by proline oxidase between oxidized low-density lipoproteins and autophagy provides a functional link between obesity and increased cancer risk.

References

  1. Nat Rev Cancer. 2004 Mar;4(3):177-83 [PMID: 14993899]
  2. Cancer Cell. 2005 Jun;7(6):499-500 [PMID: 15950897]
  3. J Nutr. 2008 Oct;138(10):2040S-2044S [PMID: 18806121]
  4. Mol Cell Biochem. 2007 Jan;295(1-2):85-92 [PMID: 16874462]
  5. J Biol Chem. 2002 Feb 8;277(6):4223-31 [PMID: 11704682]
  6. Biochem Biophys Res Commun. 1981 Aug 14;101(3):1018-25 [PMID: 6946770]
  7. Int J Cardiol. 2008 Nov 28;130(3):310-8 [PMID: 18672301]
  8. Eur J Biochem. 1977 Dec;81(3):599-607 [PMID: 598383]
  9. Cancer. 1978 Sep;42(3):1280-3 [PMID: 212173]
  10. FEBS Lett. 2008 Jul 23;582(17):2615-9 [PMID: 18588890]
  11. J Cell Biol. 2005 Jun 20;169(6):977-85 [PMID: 15967816]
  12. J Clin Invest. 1979 Nov;64(5):1365-70 [PMID: 500817]
  13. Nature. 2007 Mar 8;446(7132):153-8 [PMID: 17344846]
  14. J Cell Biochem. 2009 Jul 1;107(4):759-68 [PMID: 19415679]
  15. Annu Rev Pathol. 2006;1:119-50 [PMID: 18039110]
  16. Mol Pharmacol. 2007 Sep;72(3):674-85 [PMID: 17535976]
  17. Oncogene. 2008 Dec 4;27(53):6729-37 [PMID: 18794809]
  18. Nat Genet. 2009 Sep;41(9):1016-21 [PMID: 19648921]
  19. Oncogene. 2010 Sep 2;29(35):4914-24 [PMID: 20562915]
  20. Cancer Cell Int. 2005 Feb 08;5(1):1 [PMID: 15701164]
  21. Amino Acids. 2008 Nov;35(4):681-90 [PMID: 18401543]
  22. J Cell Physiol. 1982 Mar;110(3):255-61 [PMID: 6896335]
  23. Amino Acids. 2008 Nov;35(4):719-30 [PMID: 18369526]
  24. J Mol Biol. 2006 Jun 23;359(5):1364-77 [PMID: 16730026]
  25. Endocr Rev. 2006 Dec;27(7):728-35 [PMID: 17018837]
  26. Exp Biol Med (Maywood). 2006 Jul;231(7):1271-81 [PMID: 16816134]
  27. J Biol Chem. 2007 Feb 16;282(7):4524-4532 [PMID: 17182618]
  28. J Biol Chem. 1983 Aug 25;258(16):9774-9 [PMID: 6193109]
  29. J Cell Mol Med. 2011 Jan;15(1):109-18 [PMID: 19845817]
  30. Arch Biochem Biophys. 1995 Apr 1;318(1):25-9 [PMID: 7726568]
  31. Amino Acids. 2008 Nov;35(4):665-72 [PMID: 18401542]
  32. PPAR Res. 2008;2008:181047 [PMID: 18528526]
  33. J Biol Chem. 2008 Apr 18;283(16):10485-92 [PMID: 18287100]
  34. Pharmacol Ther. 2009 May;122(2):97-108 [PMID: 19285105]
  35. Arch Biochem Biophys. 1983 Aug;225(1):95-101 [PMID: 6688511]
  36. Cancer Res. 2009 Aug 15;69(16):6414-22 [PMID: 19654292]
  37. Nat Rev Cancer. 2008 Jan;8(1):51-6 [PMID: 18046334]
  38. Nature. 1998 Sep 10;395(6698):137-43 [PMID: 9744270]
  39. Carcinogenesis. 2010 Mar;31(3):446-54 [PMID: 19942609]
  40. Nat Med. 2009 Sep;15(9):1010-2 [PMID: 19734877]
  41. Anal Biochem. 1977 Sep;82(1):170-6 [PMID: 907120]
  42. Arch Biochem Biophys. 1986 Jul;248(1):166-74 [PMID: 3729412]
  43. J Biol Chem. 2005 Feb 25;280(8):6742-51 [PMID: 15569667]
  44. Eur J Heart Fail. 2009 May;11(5):444-52 [PMID: 19346534]
  45. Science. 2002 Mar 29;295(5564):2387-92 [PMID: 11923519]
  46. Nat Med. 2004 Aug;10(8):789-99 [PMID: 15286780]
  47. J Biol Chem. 2007 May 11;282(19):14316-27 [PMID: 17344208]
  48. J Biol Chem. 1999 Mar 5;274(10):6754-62 [PMID: 10037775]
  49. Science. 2007 Jul 20;317(5836):337 [PMID: 17641192]
  50. Carcinogenesis. 2005 Aug;26(8):1335-42 [PMID: 15817612]
  51. J Med Genet. 2006 Dec;43(12):e58 [PMID: 17142620]
  52. Annu Rev Cell Dev Biol. 2006;22:287-309 [PMID: 16824016]
  53. Ciba Found Symp. 1977;(48):43-64 [PMID: 204465]
  54. Biochem Biophys Res Commun. 1980 Mar 28;93(2):462-70 [PMID: 6892988]
  55. Cell Cycle. 2009 Oct 15;8(20):3243-5 [PMID: 19806017]
  56. Anal Biochem. 1975 Aug;67(2):413-21 [PMID: 240291]
  57. Science. 2009 May 22;324(5930):1029-33 [PMID: 19460998]
  58. Nat Rev Mol Cell Biol. 2007 Mar;8(3):221-33 [PMID: 17318226]
  59. Cancer Sci. 2009 Aug;100(8):1382-8 [PMID: 19493276]
  60. Oncogene. 2006 Sep 14;25(41):5640-7 [PMID: 16619034]
  61. J Biol Chem. 1960 Dec;235:3499-503 [PMID: 13681369]
  62. Cancer Sci. 2009 Jan;100(1):24-8 [PMID: 19037995]
  63. J Cell Biochem. 1997 Nov 1;67(2):166-75 [PMID: 9328822]
  64. PPAR Res. 2008;2008:542694 [PMID: 18670615]
  65. Biochem Soc Trans. 2007 Aug;35(Pt 4):704-6 [PMID: 17635128]
  66. Curr Diab Rep. 2009 Jun;9(3):215-20 [PMID: 19490823]
  67. Nature. 1997 Sep 18;389(6648):300-5 [PMID: 9305847]
  68. Nat Rev Immunol. 2004 Aug;4(8):617-29 [PMID: 15286728]
  69. Autophagy. 2007 Nov-Dec;3(6):542-5 [PMID: 17611390]
  70. Int J Cancer. 1998 Nov 23;78(5):629-35 [PMID: 9808534]
  71. Curr Top Cell Regul. 1985;25:91-132 [PMID: 2410198]
  72. J Cell Biochem. 2005 Dec 1;96(5):1086-94 [PMID: 16167338]
  73. Am J Clin Nutr. 2003 Nov;78(5):979-84 [PMID: 14594785]
  74. Int Rev Connect Tissue Res. 1970;5:1-91 [PMID: 5500436]
  75. Nature. 2002 Dec 19-26;420(6917):860-7 [PMID: 12490959]
  76. Cancer Res. 2001 Mar 1;61(5):1810-5 [PMID: 11280728]
  77. Annu Rev Biochem. 1980;49:1005-61 [PMID: 6250440]
  78. J Cell Physiol. 2007 Apr;211(1):19-26 [PMID: 17167774]
  79. J Nutr. 2008 Oct;138(10):2025S-2031S [PMID: 18806119]
  80. Methods Mol Biol. 2009;554:165-81 [PMID: 19513674]
  81. J Urol. 2001 Nov;166(5):1698-701 [PMID: 11586205]
  82. Biopolymers. 2005;80(6):800-14 [PMID: 15929029]
  83. J Nutr. 2008 Oct;138(10):2008S-2015S [PMID: 18806116]
  84. Carcinogenesis. 1985 Apr;6(4):501-4 [PMID: 3986956]
  85. Eur J Pediatr. 2005 Jan;164(1):31-6 [PMID: 15517380]
  86. J Nutr. 2008 Oct;138(10):2045S-2049S [PMID: 18806122]
  87. Nat Rev Immunol. 2005 Nov;5(11):844-52 [PMID: 16239903]
  88. Amino Acids. 2008 Nov;35(4):655-64 [PMID: 18506409]
  89. Circulation. 2008 Jul 1;118(1):75-83 [PMID: 18559699]
  90. Amino Acids. 2008 Nov;35(4):673-9 [PMID: 18528746]
  91. Amino Acids. 2008 Nov;35(4):739-52 [PMID: 18340504]
  92. Mol Cell Biochem. 1998 Dec;189(1-2):177-83 [PMID: 9879669]
  93. J Biol Chem. 2006 Jan 27;281(4):2044-52 [PMID: 16303758]
  94. J Biol Chem. 2005 Dec 23;280(51):41928-39 [PMID: 16223732]
  95. Bioessays. 2003 Feb;25(2):174-81 [PMID: 12539244]
  96. Am J Hum Genet. 2005 Mar;76(3):409-20 [PMID: 15662599]
  97. J Biol Chem. 1989 Jun 5;264(16):9352-8 [PMID: 2722838]
  98. J Biol Chem. 2007 Feb 2;282(5):3293-301 [PMID: 17135241]
  99. Trends Biochem Sci. 1999 Feb;24(2):68-72 [PMID: 10098401]
  100. Curr Pharm Des. 2009;15(12):1349-57 [PMID: 19355973]
  101. Biochem J. 1974 Mar;138(3):425-35 [PMID: 4154743]
  102. EMBO J. 2009 Oct 7;28(19):3015-26 [PMID: 19713938]
  103. Hum Mol Genet. 2000 Nov 22;9(19):2853-8 [PMID: 11092761]
  104. Amino Acids. 2008 Nov;35(4):761-70 [PMID: 18651095]
  105. Anal Biochem. 1976 Aug;74(2):430-40 [PMID: 962101]
  106. Cell. 2006 Jul 14;126(1):107-20 [PMID: 16839880]
  107. Cell Death Differ. 2008 Oct;15(10):1572-81 [PMID: 18551130]
  108. J Biol Chem. 2003 Mar 14;278(11):9784-9 [PMID: 12514185]
  109. Amino Acids. 2008 Nov;35(4):703-10 [PMID: 18431533]
  110. Vasc Endovascular Surg. 2009 Apr-May;43(2):121-31 [PMID: 18799500]
  111. Biochim Biophys Acta. 1982 Dec 17;719(3):480-7 [PMID: 7150655]
  112. Clin Biochem. 2007 Oct;40(15):1129-34 [PMID: 17673194]
  113. Science. 1956 Feb 24;123(3191):309-14 [PMID: 13298683]
  114. J Biol Chem. 2009 Sep 25;284(39):26482-92 [PMID: 19635803]

Grants

  1. Z01 BC010743/Intramural NIH HHS
  2. ZIA BC010743/Intramural NIH HHS
  3. ZIA BC010744/Intramural NIH HHS
  4. HHSN27612080001/PHS HHS

MeSH Term

AMP-Activated Protein Kinases
Apoptosis
Autophagy
Collagen
Gene Expression Regulation, Enzymologic
Humans
Intracellular Signaling Peptides and Proteins
Matrix Metalloproteinases
PPAR gamma
Proline
Proline Oxidase
Protein Serine-Threonine Kinases
Reactive Oxygen Species
Signal Transduction
TOR Serine-Threonine Kinases
Tumor Suppressor Protein p53

Chemicals

Intracellular Signaling Peptides and Proteins
PPAR gamma
Reactive Oxygen Species
Tumor Suppressor Protein p53
Collagen
Proline
Proline Oxidase
MTOR protein, human
Protein Serine-Threonine Kinases
TOR Serine-Threonine Kinases
AMP-Activated Protein Kinases
Matrix Metalloproteinases

Word Cloud

Created with Highcharts 10.0.0prolinestressmetabolicoxidaseProlinesignalingdegradationelectronsproduceeffectsautophagyproteinogenicsecondaryaminoacidmetabolizedfamilyenzymesrespondingparticipatingCollagenextracellularmatrixconnectivetissueboneabundantreservoirMatrixmetalloproteinasesdegradingcollagenactivatedmakeavailablefirstenzymeinducedp53peroxisomeproliferator-activatedreceptorgammaPPARgammaligandsAMP-activatedproteinkinasedownregulatingmTORMetabolismgeneratesROSinitiatesvarietydownstreamincludingblockadecellcycleapoptosiscanalsoenterelectrontransportchainadenosinetriphosphatesurvivalnutrientPyrroline-5-carboxylateproductoxidationrecycledbackredoxtransferssequentiallyconvertedglutamatealpha-ketoglutaratelatteraugmentsprolylhydroxylationhypoxia-induciblefactor-1alphaproteasomalwelldecreasedlevelstumorssupportroletumorsuppressormechanismdecreasemediatedspecificmicroRNAoxidizedlow-densitylipoproteinsprovidesfunctionallinkobesityincreasedcancerriskmetabolismmicroenvironmental

Similar Articles

Cited By